Prevalence of Asthma and Allergies Among Children in UAE

NCT ID: NCT03878680

Last Updated: 2020-07-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

3737 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-04-30

Study Completion Date

2019-06-26

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Multicenter, cross-sectional study to recruit a random sample of 6000 children via school class registers: 3000 children aged 13-14 years and 3000 children aged 6-7 years.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Multicenter, cross-sectional study to recruit a random sample of 6000 children via school class registers: 3000 children aged 13-14 years and 3000 children aged 6-7 years.Standard ISAAC core questions for wheezing, rhinitis, and atopic dermatitis will be used. The ISAAC questionnaire has been validated by the World Health Organization and translated into many languages, and used in many countries. In this study, the Arabic and English version will be used. In addition, questions regarding exposure to Arabian incense "Bokhor" and smoking questions of the environmental questionnaire will be included.

ISAAC Questionnaires

1. Core questionnaire on wheezing.
2. Core questionnaire on rhinitis.
3. Core questionnaire on atopic dermatitis.
4. Smoking questions of the environmental questionnaire.
5. Video questionnaire on wheezing (only for 13-14 years age group, if applicable)

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Asthma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

13-14 years age group

Children with age 13-14 years at the time of questionnaires completion, and residing in Dubai and the Northern Emirates of UAE.

Study questionnaires

Intervention Type OTHER

Completion of the International study of Asthma and Allergies in Children(ISAAC)core questionnaires:

1. Core questionnaire on wheezing.
2. Core questionnaire on rhinitis.
3. Core questionnaire on atopic dermatitis.

6-7 years age goup

Children with age 6-7 years at the time of questionnaires completion, and residing in Dubai and the Northern Emirates of UAE.

Study questionnaires

Intervention Type OTHER

Completion of the International study of Asthma and Allergies in Children(ISAAC)core questionnaires:

1. Core questionnaire on wheezing.
2. Core questionnaire on rhinitis.
3. Core questionnaire on atopic dermatitis.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Study questionnaires

Completion of the International study of Asthma and Allergies in Children(ISAAC)core questionnaires:

1. Core questionnaire on wheezing.
2. Core questionnaire on rhinitis.
3. Core questionnaire on atopic dermatitis.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Children with age 6 to 7 years or with age 13 to 14 years at the time of questionnaires completion, and residing in Dubai and the Northern Emirates of UAE.
* Children aged 6 to 7 years or 13 to14 years, whose legal guardians give their consent.
* Able to give assent in the 13 to 14 years group.
* Able to comprehend and answer the questionnaire themselves in the 13 to 14 years group.

Exclusion Criteria

* Aged 13 to 14 years and unable to answer the questionnaire due to physical or mental disability.
* Parent or legal guardian refuses sign and return consent for the 6 to 7 years group and the 13 to 14 years group.
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AstraZeneca

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Research Site

Ajman, , United Arab Emirates

Site Status

Research Site

Dubai, , United Arab Emirates

Site Status

Research Site

FUJ, , United Arab Emirates

Site Status

Research Site

Ras al-Khaimah, , United Arab Emirates

Site Status

Research Site

Sharjah city, , United Arab Emirates

Site Status

Research Site

UMQ, , United Arab Emirates

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Arab Emirates

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

D2287R00142

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Asthma in Children
NCT01286532 COMPLETED
The Effect of Asthma Flare-up Clinic After Exacerbation
NCT06201728 ENROLLING_BY_INVITATION NA
Asthma Control Study 2011
NCT01298739 COMPLETED
The Virtual Asthma Clinic
NCT00562081 TERMINATED PHASE4